PECAM1 and atrial fibrillation: cTNT (p < 0.001), CD31 (p < 0.01), and α-SMA (p < 0.05), suggesting ICHD AF-MSCs have a poorer cardiovascular differentiation potential in comparison to the normal AF-MSCs (Figure 4).